Cargando…
SARS-CoV-2 infections in melanoma patients treated with PD-1 inhibitors: A survey of the German ADOREG melanoma registry
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699158/ https://www.ncbi.nlm.nih.gov/pubmed/33342623 http://dx.doi.org/10.1016/j.ejca.2020.11.015 |
| _version_ | 1783615984719888384 |
|---|---|
| author | Moritz, Rose K.C. Gutzmer, Ralf Zimmer, Lisa Meier, Friedegund Ahmed, Misbah S. Sell, Sabine Schlaak, Max Kapp, Florian Sachse, Michael M. Haferkamp, Sebastian Welzel, Julia Kähler, Katharina C. Weichenthal, Michael |
| author_facet | Moritz, Rose K.C. Gutzmer, Ralf Zimmer, Lisa Meier, Friedegund Ahmed, Misbah S. Sell, Sabine Schlaak, Max Kapp, Florian Sachse, Michael M. Haferkamp, Sebastian Welzel, Julia Kähler, Katharina C. Weichenthal, Michael |
| author_sort | Moritz, Rose K.C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7699158 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76991582020-12-01 SARS-CoV-2 infections in melanoma patients treated with PD-1 inhibitors: A survey of the German ADOREG melanoma registry Moritz, Rose K.C. Gutzmer, Ralf Zimmer, Lisa Meier, Friedegund Ahmed, Misbah S. Sell, Sabine Schlaak, Max Kapp, Florian Sachse, Michael M. Haferkamp, Sebastian Welzel, Julia Kähler, Katharina C. Weichenthal, Michael Eur J Cancer Letter to the Editor Elsevier Ltd. 2021-02 2020-11-28 /pmc/articles/PMC7699158/ /pubmed/33342623 http://dx.doi.org/10.1016/j.ejca.2020.11.015 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Moritz, Rose K.C. Gutzmer, Ralf Zimmer, Lisa Meier, Friedegund Ahmed, Misbah S. Sell, Sabine Schlaak, Max Kapp, Florian Sachse, Michael M. Haferkamp, Sebastian Welzel, Julia Kähler, Katharina C. Weichenthal, Michael SARS-CoV-2 infections in melanoma patients treated with PD-1 inhibitors: A survey of the German ADOREG melanoma registry |
| title | SARS-CoV-2 infections in melanoma patients treated with PD-1 inhibitors: A survey of the German ADOREG melanoma registry |
| title_full | SARS-CoV-2 infections in melanoma patients treated with PD-1 inhibitors: A survey of the German ADOREG melanoma registry |
| title_fullStr | SARS-CoV-2 infections in melanoma patients treated with PD-1 inhibitors: A survey of the German ADOREG melanoma registry |
| title_full_unstemmed | SARS-CoV-2 infections in melanoma patients treated with PD-1 inhibitors: A survey of the German ADOREG melanoma registry |
| title_short | SARS-CoV-2 infections in melanoma patients treated with PD-1 inhibitors: A survey of the German ADOREG melanoma registry |
| title_sort | sars-cov-2 infections in melanoma patients treated with pd-1 inhibitors: a survey of the german adoreg melanoma registry |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699158/ https://www.ncbi.nlm.nih.gov/pubmed/33342623 http://dx.doi.org/10.1016/j.ejca.2020.11.015 |
| work_keys_str_mv | AT moritzrosekc sarscov2infectionsinmelanomapatientstreatedwithpd1inhibitorsasurveyofthegermanadoregmelanomaregistry AT gutzmerralf sarscov2infectionsinmelanomapatientstreatedwithpd1inhibitorsasurveyofthegermanadoregmelanomaregistry AT zimmerlisa sarscov2infectionsinmelanomapatientstreatedwithpd1inhibitorsasurveyofthegermanadoregmelanomaregistry AT meierfriedegund sarscov2infectionsinmelanomapatientstreatedwithpd1inhibitorsasurveyofthegermanadoregmelanomaregistry AT ahmedmisbahs sarscov2infectionsinmelanomapatientstreatedwithpd1inhibitorsasurveyofthegermanadoregmelanomaregistry AT sellsabine sarscov2infectionsinmelanomapatientstreatedwithpd1inhibitorsasurveyofthegermanadoregmelanomaregistry AT schlaakmax sarscov2infectionsinmelanomapatientstreatedwithpd1inhibitorsasurveyofthegermanadoregmelanomaregistry AT kappflorian sarscov2infectionsinmelanomapatientstreatedwithpd1inhibitorsasurveyofthegermanadoregmelanomaregistry AT sachsemichaelm sarscov2infectionsinmelanomapatientstreatedwithpd1inhibitorsasurveyofthegermanadoregmelanomaregistry AT haferkampsebastian sarscov2infectionsinmelanomapatientstreatedwithpd1inhibitorsasurveyofthegermanadoregmelanomaregistry AT welzeljulia sarscov2infectionsinmelanomapatientstreatedwithpd1inhibitorsasurveyofthegermanadoregmelanomaregistry AT kahlerkatharinac sarscov2infectionsinmelanomapatientstreatedwithpd1inhibitorsasurveyofthegermanadoregmelanomaregistry AT weichenthalmichael sarscov2infectionsinmelanomapatientstreatedwithpd1inhibitorsasurveyofthegermanadoregmelanomaregistry |